CpG island methylation according to the histologic patterns of early gastric adenocarcinoma

Korean Journal of Pathology

Volumn 45, Issue 5, 2011, Pages 469-476

  Choi, Junjeong ^a   Cho, Mee Yon ^a   Jung, So Young ^a   Jan, Khalilullah Mia ^a   Kim, Hyun Soo ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Adenoma; CpG islands; DNA methylation; Dysplasia; Stomach

Indexed keywords

EID: 84863044988     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2011.45.5.469     Document Type: Article

References (29)

1. National Cancer Information Center. Major fraction of cancer deaths. 2011 [Internet]. Goyang: National Cancer Information Center; c2011 [cited 2011 Jul 4]. Available from: http://www.cancer.go.kr/ncic/cics_f/02/022/index.html.
2. Carneiro F, Oliveira C, Suriano G, Seruca R. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol 2008; 61: 25-30.
3. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010; 48-9.
4. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6: 107-16.
5. Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 2011; 68: 1681-702.
6. Lee JH, Park SJ, Abraham SC, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004; 23: 4646-54.
7. Choi IS, Wu TT. Epigenetic alterations in gastric carcinogenesis. Cell Res 2005; 15: 247-54.
8. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
9. Stadtländer CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20: 2195-208.
10. Joo JK, Kim SH, Kim HG, et al. CpG methylation of transcription factor 4 in gastric carcinoma. Ann Surg Oncol 2010; 17: 3344-53.
11. Nakamura J, Kitajima Y, Kai K, et al. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. Am J Pathol 2011; 178: 515-24.
12. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010; 61-2.
13. Kumarasinghe MP, Lim TK, Ooi CJ, Luman W, Tan SY, Koh M. Tubule neck dysplasia: precursor lesion of signet ring cell carcinoma and the immunohistochemical profile. Pathology 2006; 38: 468-71.
14. Carneiro F, Huntsman DG, Smyrk TC, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004; 203: 681-7.
15. Watanabe Y, Kim HS, Castoro RJ, et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 2009; 136: 2149-58.
16. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60: 1835-9.
17. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9.
18. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001; 7: 584-9.
19. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 2003; 83: 519-26.
20. Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, Shinomura Y. Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 2011; 83: 241-9.
21. Hibi K, Sakata M, Kitamura YH, et al. Demethylation of the CD133 gene is frequently detected in early gastric carcinoma. Anticancer Res 2010; 30: 1201-3.
22. Lash RH, Lauwers GY, Odze RD, Genta RM. Inflammatory disorders of stomach. In: Odze RD, Goldblum JR, eds. Surgical pathology of the GI tract, liver, biliary tract and pancreas. 2nd ed. Philadelphia: Saunders, 2009; 269-320.
23. Yi JM, Tsai HC, Glöckner SC, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008; 68: 8094-103.
24. Baba T, Convery PA, Matsumura N, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009; 28: 209-18.
25. Bieker JJ. Krüppel-like factors: three fingers in many pies. J Biol Chem 2001; 276: 34355-8.
26. Wei D, Kanai M, Huang S, Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 2006; 27: 23-31.
27. Cho YG, Song JH, Kim CJ, et al. Genetic and epigenetic analysis of the KLF4 gene in gastric cancer. APMIS 2007; 115: 802-8.
28. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12(3 Pt 1): 989-95.
29. Qian X, Huang C, Cho CH, Hui WM, Rashid A, Chan AO. E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett 2008; 263: 107-13.